Philly’s opioid addiction crisis is constantly evolving. Local health care workers and researchers explain some of the latest ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...

In Philadelphia, fatal overdoses are the No. 3 cause of death after heart disease and cancer. That's been the case each year since 2016, except in 2020 and 2021 when COVID-19 deaths outpaced overdose ...

Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow AscentTM, an FDA-cleared non-invasive, drug-free, ...

Withdrawal symptoms from opioids can be very uncomfortable but are rarely life-threatening. This article will discuss opioid withdrawal symptoms, signs of opioid use disorder (OUD ...

Some of the experts advocated for switching patients to buprenorphine, which diminishes the effects of physical dependency to opioids, such as withdrawal symptoms and cravings, and is used to ...

Dallas, TX, March 05, 2025 (GLOBE NEWSWIRE) — Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for ...

Knowledge is power for family members, for communities, for health care providers, and for the men and women — sons and ...

The researchers found that the use of buprenorphine, a type of opioid that helps reduce withdrawal symptoms and cravings in opioid use disorder, was associated with increased inflammation and ...

Sublocade is a buprenorphine-containing long-acting injectable medicine that reduces cravings and withdrawal by partially triggering opioid receptors and preventing stronger opioids from attaching ...

It’s called a neuro-electrode treatment to help battle opioid withdrawal, which hundreds of people have benefited from. “A barrier to a lot of people who really want help and don’t get it is ...